Modifying Antisolvent Addition Technique for Ionic Co-Crystallization of Paracetamol (PCM) and Metal Sulfates

Article Preview

Abstract:

This investigation reports the successful synthesis and characterization of a co-crystal composed of paracetamol (PCM) and metal sulfates of zinc and iron using an adapted antisolvent addition technique which leveraged the antagonistic solvent affinities of PCM and the metal sulfates. Ethanol and water acted as solvents for PCM and the metal sulfates, respectively, while simultaneously serving as antisolvents for the other constituent. Scanning Electron Microscopy (SEM) micrographs revealed crystals exhibiting a rod-like structure and a surface covered by flakes, which are both characteristic features of PCM and zinc sulfate, suggesting the formation of a new crystalline phase. This is further supported by the distinct powder x-ray diffraction pattern for the co-crystal when compared with that of the individual constituents. Analysis of Fourier Transform Infrared (FTIR) spectra suggests that the interacting functional groups which formed a new hydrogen bond network are the amide N-H and the water in the aquo complex formed by the metals in aqueous solutions. The findings highlight the simplicity of the crystallization technique and provide insights into the structural and mechanistic aspects of organic-inorganic co-crystals. This study contributes to the advancement of co-crystal engineering and lays the groundwork for exploring the pharmaceutical and functional applications of PCM-metal sulfate co-crystals.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

141-146

Citation:

Online since:

March 2026

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2026 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] Karimi-Jafari, M.; Padrela, L.; Walker, G. M.; Croker, D. M. Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications. Cryst. Growth Des. 2018, 18 (10), 6370–6387.

DOI: 10.1021/acs.cgd.8b00933

Google Scholar

[2] Charoenchaitrakool, M.; Roubroum, T.; Sudsakorn, K. Processing of a Novel Mefenamic Acid−paracetamol−nicotinamide Cocrystal Using Gas Anti-Solvent Process. J. CO2 Util. 2022, 62, 102080.

DOI: 10.1016/j.jcou.2022.102080

Google Scholar

[3] Bhowmik, A.; Bamane, S.; Saxena, A. K.; Mishra, M. K. Caffeine vs. Theophylline Cocrystals: Insights into Structure–Mechanical Behavior and Piezoelectricity. Cryst. Growth Des. 2025, 25 (13), 5007–5021.

DOI: 10.1021/acs.cgd.5c00491

Google Scholar

[4] Rodrigues, M.; Baptista, B.; Lopes, J. A.; Sarraguça, M. C. Pharmaceutical Cocrystallization Techniques. Advances and Challenges. Int. J. Pharm. 2018, 547 (1–2), 404–420.

DOI: 10.1016/j.ijpharm.2018.06.024

Google Scholar

[5] Ngilirabanga, J. B.; Samsodien, H. Pharmaceutical Co‐crystal: An Alternative Strategy for Enhanced Physicochemical Properties and Drug Synergy. Nano Sel. 2021, 2 (3), 512–526.

DOI: 10.1002/nano.202000201

Google Scholar

[6] Al-Dulaimi, A.; Al-kotaji, M.; Abachi, F. Paracetamol/ Naproxen Co-Crystals; a Simple Way for Improvement of Flowability, Tableting and Dissolution Properties. Iraqi J. Pharm. 2021, 18 (1), 1–19.

DOI: 10.33899/iphr.2021.168798

Google Scholar

[7] Schenck, L.; Erdemir, D.; Saunders Gorka, L.; Merritt, J. M.; Marziano, I.; Ho, R.; Lee, M.; Bullard, J.; Boukerche, M.; Ferguson, S.; Florence, A. J.; Khan, S. A.; Sun, C. C. Recent Advances in Co-Processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies. Mol. Pharm. 2020, 17 (7), 2232–2244.

DOI: 10.1021/acs.molpharmaceut.0c00198

Google Scholar

[8] Latif, S.; Abbas, N.; Hussain, A.; Arshad, M. S.; Bukhari, N. I.; Afzal, H.; Riffat, S.; Ahmad, Z. Development of Paracetamol-Caffeine Co-Crystals to Improve Compressional, Formulation and in Vivo Performance. Drug Dev. Ind. Pharm. 2018, 44 (7), 1099–1108.

DOI: 10.1080/03639045.2018.1435687

Google Scholar

[9] Liu, Y.; Gabriele, B.; Davey, R. J.; Cruz-Cabeza, A. J. Concerning Elusive Crystal Forms: The Case of Paracetamol. J. Am. Chem. Soc. 2020, 142 (14), 6682–6689.

DOI: 10.1021/jacs.0c00321

Google Scholar

[10] Keshavarz, L.; Pishnamazi, M.; Rao Khandavilli, U. B.; Shirazian, S.; Collins, M. N.; Walker, G. M.; Frawley, P. J. Tailoring Crystal Size Distributions for Product Performance, Compaction of Paracetamol. Arab. J. Chem. 2021, 14 (4), 103089.

DOI: 10.1016/j.arabjc.2021.103089

Google Scholar

[11] Du, W.; Yang, J.; Peng, Q.; Liang, X.; Mao, H. Comparison Study of Zinc Nanoparticles and Zinc Sulphate on Wheat Growth: From Toxicity and Zinc Biofortification. Chemosphere 2019, 227, 109–116.

DOI: 10.1016/j.chemosphere.2019.03.168

Google Scholar

[12] Polekkad, A.; Franklin, M. E. E.; Pushpadass, H. A.; Battula, S. N.; Rao, S. B. N.; Pal, D. T. Microencapsulation of Zinc by Spray-Drying: Characterisation and Fortification. Powder Technol. 2021, 381, 1–16.

DOI: 10.1016/j.powtec.2020.12.009

Google Scholar

[13] Ramesh, V. Third Order Non Linear Material of Zinc Sulphate Doped L-Threonine Dihydrogen Phosphate Single Crystal. Mater. Today Proc. 2020, 33, 4177–4179.

DOI: 10.1016/j.matpr.2020.07.060

Google Scholar

[14] Zapata, F.; López-Fernández, A.; Ortega-Ojeda, F.; Quintanilla, G.; García-Ruiz, C.; Montalvo, G. Introducing ATR-FTIR Spectroscopy through Analysis of Acetaminophen Drugs: Practical Lessons for Interdisciplinary and Progressive Learning for Undergraduate Students. J. Chem. Educ. 2021, 98 (8), 2675–2686.

DOI: 10.1021/acs.jchemed.0c01231

Google Scholar

[15] Budziak-Wieczorek, I.; Maciołek, U. Synthesis and Characterization of a (−)-Epicatechin and Barbituric Acid Cocrystal: Single-Crystal X-Ray Diffraction and Vibrational Spectroscopic Studies. ACS Omega 2021, 6 (12), 8199–8209.

DOI: 10.1021/acsomega.0c06239

Google Scholar